Last checked at 16 Feb 2021 15:00
Scancell Holdings Plc
("Scancell" or the "Company")
BLOCK LISTING SIX MONTHLY RETURN
Date: 16 February 2021
Name of applicant: | Scancell Holdings plc | |||
Name of scheme: | Convertible Loan Notes Shares
| |||
Period of return: | From: | 12 August 2020 | To: | 15 February 2021 |
Number of securities originally admitted at date of admission | 96,774,193 ordinary shares of £0.001 each 12 August 2020
| |||
Balance of unallotted securities under scheme(s) from previous return: | 96,774,193 ordinary shares of £0.001 each
| |||
Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): | Nil | |||
Less: Number of securities issued/allotted under scheme(s) during period: | 69,719,566 ordinary shares of £0.001 each | |||
Equals: Balance under scheme(s) not yet issued/allotted at end of period: | 27,054,627 ordinary shares of £0.001 each
| |||
|
|
|
|
|
Name of contact: | Dr Cliff Holloway, CEO |
Telephone number of contact: | +44 (0) 20 3727 1000 |
For Further Information:
Scancell Holdings plc |
|
|
Dr John Chiplin, Chairman |
| +44 (0) 20 3727 1000 |
Dr Cliff Holloway, CEO |
|
|
|
|
|
Panmure Gordon (UK) Limited |
|
|
Freddy Crossley/Emma Earl (Corporate Finance) |
| +44 (0) 20 7886 2500 |
Rupert Dearden (Corporate Broking) |
|
|
|
|
|
FTI Consulting |
|
|
Simon Conway/Natalie Garland-Collins |
| +44 (0) 20 3727 1000 |